How your pharmacy partners impact your Star Ratings August 01, 2016 By Marc O'Connor Are you tracking your prospective pharmacy partners to measure their potential impact on your Star Rating? You should be. Put drug development to work for diabetic patients Although the diabetes pipeline is not large, we continue to have progress in meeting the unmet needs of patients with diabetes. Diabetic patients benefit most from personalized strategies May 01, 2016 By Karen Appold Personalization is the key to a healthcare experience that optimizes outcomes, improves the customer experience and, ultimately, lowers costs to the healthcare system. Find out why it’s especially key for diabetic patients. Innovative diabetes cost-reduction strategies April 03, 2016 By Aine Cryts Here are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it. Diabetes drug spending on the rise March 31, 2016 By Tracey Walker The sheer volume of diabetes patients has made it a big driver of medication spending. Here are some important formulary considerations. Strategies to reduce diabetes health management costs March 03, 2016 By Karen Appold Rob Danoff, DO, of Aria Health System, explains what should be done to reduce health management costs, while improving care of diabetic patients. How new tech, treatments impact diabetes costs March 01, 2016 By Karen Appold In this Q&A, experts discuss how emerging treatments and technologies are affecting diabetes costs. Hospital pharmacists improve management of diabetes patients November 10, 2015 By Anthony Vecchione Medication reconciliation, inpatient care, med safety, discharge education, transitions of care, medication adherence — these are only some of the ways pharmacists can benefit the healthcare team. There are plenty more. FDA approves long-acting insulin drugs September 28, 2015 By Erin Bastick FDA approved Tresiba (insulin degludec injection, Novo Nordisk) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection, Novo Nordisk) for the treatment of diabetes mellitus.